Physician profile
Danielle Martin
NPI 1144634999
$334.02
in general payments reported to CMS, 2019-2025
9 companies · $29.80 in 2025
The $29.80 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $151 · 2023: $29.16 · 2024: $124 · 2025: $29.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $168 · Education: $14.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $167.84 |
| Education | $14.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurinia Pharma U.S., INC. | $86.56 | 2022-2024 | Lupkynis |
| Astrazeneca Pharmaceuticals LP | $63.39 | 2022 | |
| Ardelyx, INC. | $47.33 | 2024-2025 | Ibsrela |
| Cardiva Medical, INC. | $41.43 | 2024 | Optowire, Cardiva Vascade Mvp Vvcs 6-12f |
| Fresenius USA Marketing, INC. | $29.87 | 2022 | |
| Amgen INC. | $23.48 | 2024 | Krystexxa |
| Travere Therapeutics, INC. | $14.72 | 2023-2025 | Filspari |
| Lilly USA, LLC | $14.04 | 2024 | Jardiance |
| Horizon Therapeutics Plc | $13.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.